Brief: Omega Therapeutics Reports First Quarter 2022 Financial Results And Highlights Recent Company Progress
04/05/2022 23:03
May 4 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT COMPANY PROGRESS
* $200.8 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES AT END OF Q1
* QTRLY LOSS PER SHARE $0.42
* Q1 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnc7FBMLa
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence